摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1,3-dimethyl-4-vinyl-1H-pyrazole | 90124-61-1

中文名称
——
中文别名
——
英文名称
1,3-dimethyl-4-vinyl-1H-pyrazole
英文别名
4-ethenyl-1,3-dimethyl-1H-pyrazole;4-ethenyl-1,3-dimethylpyrazole
1,3-dimethyl-4-vinyl-1H-pyrazole化学式
CAS
90124-61-1
化学式
C7H10N2
mdl
——
分子量
122.17
InChiKey
LNMCFPSTJULCAS-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.4
  • 重原子数:
    9
  • 可旋转键数:
    1
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.29
  • 拓扑面积:
    17.8
  • 氢给体数:
    0
  • 氢受体数:
    1

文献信息

  • [EN] 4,6-DIARYLAMINOTHIAZINES AS BACE1 INHIBITORS AND THEIR USE FOR THE REDUCTION OF BETA-AMYLOID PRODUCTION<br/>[FR] 4,6-DIARYLAMINOTHIAZINES À TITRE D'INHIBITEURS DE BACE1 ET LEUR UTILISATION POUR RÉDUIRE LA PRODUCTION DES BÊTA-AMYLOÏDES
    申请人:BRISTOL MYERS SQUIBB CO
    公开号:WO2014098831A1
    公开(公告)日:2014-06-26
    Compounds of formula (I), including pharmaceutically acceptable salts thereof, are set forth herein: (I) wherein R1 and R2 are independently hydrogen, or -CH3; or R1 and R2 can join together in a ring by adding -(CH2)4-; R3 is hydrogen or C1-C3 alkyl; Y and Z are independently a C6-C10- aryl group or a 5-10 membered heterocyclic group which can be further substituted with from 0-3 substituents selected from the group of halogen, hydroxy, amino, C1-4alkylamino, C1-4 dialkylamino, haloC1-4 alkyl, CN, C1-C6 alkyl or cycloalkyl, C1-C6 alkoxy, -C=OC1-4 alkyl, -S02C1-4 alkyl, and C2-C4 alkynyl; A is selected from the group of phenyl, benzyl, oxazolyl, thiazolyl, isoxazolyl, imidazolyl, pyrazolyl, pyridyl, pyrimidinyl, and pyrazinyl groups which can be further substituted with from 0-3 substituents selected from the group of halogen, hydroxy, amino, C1-4alkylamino, C1-4 dialkylamino, haloC1-4 alkyl, hydroxyC1-6 alkyl, CN, C1-C6 alkyl or cycloalkyl, C1-C6 alkoxy, and C2-C4 alkynyl; L is -NHCO-, or is a single bond; and L and Z together can be absent.
    化合物的结构式(I),包括其药用盐,如下所示:(I),其中R1和R2分别是氢或-CH3;或者R1和R2可以通过添加-(CH2)4-在环中连接在一起;R3是氢或C1-C3烷基;Y和Z分别是C6-C10芳基或5-10成员杂环基,可以进一步用来自卤素、羟基、基、C1-4烷基基、C1-4二烷基基、卤代C1-4烷基、CN、C1-C6烷基或环烷基、C1-C6烷氧基、-C=OC1-4烷基、-S02C1-4烷基和C2-C4炔基的0-3取代基取代;A选自苯基、苄基、噁唑基、噻唑基、异噁唑基、咪唑基、吡唑基、吡啶基、嘧啶基和吡嗪基,可以进一步用来自卤素、羟基、基、C1-4烷基基、C1-4二烷基基、卤代C1-4烷基、羟基C1-6烷基、CN、C1-C6烷基或环烷基、C1-C6烷氧基和C2-C4炔基的0-3取代基取代;L为-NHCO-,或者是单键;而L和Z可以缺失。
  • [EN] "TRPSWITCH" − A STEP FUNCTION CHEMO-OPTOGENETIC LIGAND<br/>[FR] LIGAND CHIMIO-OPTOGÉNÉTIQUE À FONCTION ÉTAGÉE "TRPSWITCH"
    申请人:UNIV UTAH RES FOUND
    公开号:WO2021030165A1
    公开(公告)日:2021-02-18
    Described herein are photoswitchable compounds that can activate TRPA1 channels in neuronal and non-neuronal cells. The TRPswitch molecules allow for optical control of both the activation and deactivation of TRPA1 channels. Such compounds can be used as research tools or therapeutics.
    本文描述了可以在神经元和非神经元细胞中激活TRPA1通道的光切换化合物。TRPswitch分子可以实现对TRPA1通道的激活和去活的光学控制。这些化合物可以作为研究工具或治疗药物使用。
  • 4,6-DIARYLAMINOTHIAZINES AS BACE1 INHIBITORS AND THEIR USE FOR THE REDUCTION OF BETA-AMYLOID PRODUCTION
    申请人:BRISTOL-MYERS SQUIBB COMPANY
    公开号:US20150329506A1
    公开(公告)日:2015-11-19
    Compounds of formula (I), including pharmaceutically acceptable salts thereof, are set forth herein: (I) wherein R 1 and R 2 are independently hydrogen, or —CH 3 ; or R 1 and R 2 can join together in a ring by adding —(CH 2 ) 4 —; R 3 is hydrogen or C 1 -C 3 alkyl; Y and Z are independently a C 6 -C 10 -aryl group or a 5-10 membered heterocyclic group which can be further substituted with from 0-3 substituents selected from the group of halogen, hydroxy, amino, C 1-4 alkylamino, C 1-4 dialkylamino, haloC 1-4 alkyl, CN, C 1 -C 6 alkyl or cycloalkyl, C 1 -C 6 alkoxy, —C═OC 1-4 alkyl, —SO 2 C 1-4 alkyl, and C 2 -C 4 alkynyl; A is selected from the group of phenyl, benzyl, oxazolyl, thiazolyl, isoxazolyl, imidazolyl, pyrazolyl, pyridyl, pyrimidinyl, and pyrazinyl groups which can be further substituted with from 0-3 substituents selected from the group of halogen, hydroxy, amino, C 1-4 alkylamino, C 1-4 dialkylamino, haloC 1-4 alkyl, hydroxyC 1-6 alkyl, CN, C 1 -C 6 alkyl or cycloalkyl, C 1 -C 6 alkoxy, and C 2 -C 4 alkynyl; L is —NHCO—, or is a single bond; and L and Z together can be absent.
    本文列出了公式(I)的化合物,包括其中的药物可接受的盐:(I)其中R1和R2分别为氢或-CH3;或R1和R2可以通过添加-(CH2)4-形成环;R3为氢或C1-C3烷基;Y和Z分别为C6-C10芳基或5-10成员的杂环基,可以进一步用来自卤素、羟基、基、C1-4烷基基、C1-4双烷基基、卤C1-4烷基、CN、C1-C6烷基或环烷基、C1-C6烷氧基、-C═OC1-4烷基、-SO2C1-4烷基和C2-C4炔基的0-3个取代基进行取代;A选自苯基、苄基、噁唑基、噻唑基、异噁唑基、咪唑基、吡唑基、吡啶基、嘧啶基和吡嗪基,可以进一步用来自卤素、羟基、基、C1-4烷基基、C1-4双烷基基、卤C1-4烷基、羟基C1-6烷基、CN、C1-C6烷基或环烷基、C1-C6烷氧基和C2-C4炔基的0-3个取代基进行取代;L为-NHCO-或单键;L和Z可以一起不存在。
  • US8188080B2
    申请人:——
    公开号:US8188080B2
    公开(公告)日:2012-05-29
  • US9475784B2
    申请人:——
    公开号:US9475784B2
    公开(公告)日:2016-10-25
查看更多